[Federal Register Volume 83, Number 93 (Monday, May 14, 2018)]
[Notices]
[Pages 22270-22271]
[FR Doc No: 2018-10187]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-D-1638]

Pediatric HIV Infection: Drug Development for Treatment; Draft
Guidance for Industry; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of a draft guidance for industry entitled ``Pediatric
HIV Infection: Drug Development for Treatment.'' This guidance provides
general recommendations on the development of drug products for the
treatment of human immunodeficiency virus (HIV) infection in pediatric
patients (birth to younger than 17 years of age).

DATES: Submit either electronic or written comments on the draft
guidance by July 13, 2018 to ensure that the Agency considers your
comment on this draft guidance before it begins work on the final
version of the guidance.

ADDRESSES: You may submit comments on any guidance at any time as
follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2018-D-1638 for ``Pediatric HIV Infection: Drug Development for
Treatment; Draft Guidance for Industry; Availability.'' Received
comments will be placed in the docket and, except for those submitted
as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
    You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
    Submit written requests for single copies of the draft guidance to
the Division of Drug Information, Center for Drug Evaluation and
Research, Food and Drug Administration, 10001 New Hampshire Ave.,
Hillandale Building, 4th Floor, Silver Spring, MD 20993-0002; or to the
Office of Communication, Outreach and Development, Center for Biologics
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Building 71, Rm. 3128, Silver Spring, MD 20993-0002.
Send one self-addressed adhesive label to assist that office in
processing your requests. See the SUPPLEMENTARY INFORMATION section for
electronic access to the draft guidance document.

FOR FURTHER INFORMATION CONTACT: Yodit Belew, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, Rm. 6322, Silver Spring,

MD 20993-0002,<PHONE_NUMBER>; or Stephen Ripley, Center for Biologics
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-
402-7911.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a draft guidance for industry
entitled ``Pediatric HIV Infection: Drug Development for Treatment.''
This draft guidance provides general recommendations on the development
of products for the treatment of human immunodeficiency virus (HIV)
infection in pediatric patients (birth to younger than 17 years of
age), including recommendations on when sponsors should initiate
pediatric formulation development and begin pediatric studies to
evaluate antiretroviral drug products for the treatment of HIV
infection.
    This draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the current thinking of FDA on drug
development for treatment of pediatric HIV infection. It does not
establish any rights for any person and is not binding on FDA or the
public. You can use an alternative approach if it satisfies the
requirements of the applicable statutes and regulations. This guidance
is not subject to Executive Order 12866.

II. Electronic Access

    Persons with access to the internet may obtain the draft guidance
at either https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm, https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm, or
https://www.regulations.gov.

    Dated: May 7, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-10187 Filed 5-11-18; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 88, Number 114 (Wednesday, June 14, 2023)]
[Notices]
[Pages 38915-38917]
[FR Doc No: 2023-12660]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-97667; File No. SR-BX-2023-015]

Self-Regulatory Organizations; Nasdaq BX, Inc.; Notice of Filing
and Immediate Effectiveness of Proposed Rule Change To Amend the
Exchange's Transaction Fees at Equity 7, Section 118

June 8, 2023.
    Pursuant to section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on June 1, 2023, Nasdaq BX, Inc. (``BX'' or ``Exchange'') filed with
the Securities and Exchange Commission (``SEC'' or ``Commission'') the
proposed rule change as described in Items I, II, and III, below, which
Items have been prepared by the Exchange. The Commission is publishing
this notice to solicit comments on the proposed rule change from
interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend the Exchange's transaction fees at
Equity 7, section 118(e), as described further below.
    The text of the proposed rule change is available on the Exchange's
website at https://listingcenter.nasdaq.com/rulebook/bx/rules, at the
principal office of the Exchange, and at the Commission's Public
Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange operates on the ``taker-maker'' model, whereby it
generally pays credits to members that take liquidity and charges fees
to members that provide liquidity. Currently, the Exchange has a
schedule, at Equity 7, section 118(e), which consists of several
different credits and fees for Retail Orders \3\ and Retail Price
Improvement Orders \4\ under Rule 4780 (Retail Price Improvement
Program).
---------------------------------------------------------------------------

    \3\ Retail Orders shall mean an order type with a Non-Display
Order Attribute submitted to the Exchange by a Retail Member
Organization (as defined in Rule 4780). A Retail Order must be an
agency Order, or riskless principal Order that satisfies the
criteria of FINRA Rule 5320.03. The Retail Order must reflect
trading interest of a natural person with no change made to the
terms of the underlying order of the natural person with respect to
price (except in the case of a market order that is changed to a
marketable limit order) or side of market and that does not
originate from a trading algorithm or any other computerized
methodology. See Rule 4702(b)(6).
    \4\ Retail Price Improving (``RPI'') Orders shall mean an Order
Type with a Non-Display Order Attribute that is held on the Exchange
Book in order to provide liquidity at a price at least $0.001 better
than the NBBO through a special execution process described in Rule
4780. A Retail Price Improving Order may be entered in price
increments of $0.001. RPI Orders collectively may be referred to as
``RPI Interest.'' See Rule 4702(b)(5).
---------------------------------------------------------------------------

    Currently, the Exchange charges a fee of $0.0018 per share executed
for RPI Orders entered by a member that (i) quotes Retail Price
Improvement Orders in at least 1,200 symbols on average per day and
(ii) provides liquidity through Retail Price Improvement Orders equal
to or exceeding an average daily volume of 2,500,000 shares. The
Exchange currently charges a fee of $0.0025 per share executed for all
other RPI Orders that provide liquidity. The Exchange proposes to adopt
a new fee of $0.0020 per share executed for RPI Orders entered by a
member that (i) quotes Retail Price Improvement Orders in at least
1,200 symbols on average per day; (ii) provides liquidity through
Retail Price Improvement Orders equal to or exceeding an average daily
volume of 1,000,000 shares; and (iii) increases its average daily
volume of liquidity provided in Retail Price Improvement Orders at
least 10% relative to the month of March 2023. The Exchange hopes that
the proposed fee will encourage members to increase liquidity providing
activity in RPI Orders on the Exchange relative to March 2023. If the
proposal is effective in achieving this purpose, then the quality of
the Exchange's market will improve, particularly with respect to RPI
and Retail Orders to the benefit of all participants, especially those
who submit RPI and Retail Orders.
    At this time, the Exchange proposes to sunset the proposed fee of
$0.0020 per share executed. The fee will be available through September
30, 2023.\5\ Despite only offering this incentive for four months
(i.e., June 2023 through September 2023), the Exchange believes that it
may continue to encourage members to earn lower fees by increasing
liquidity providing activity in RPI Orders on the Exchange. The
Exchange will use this time period to evaluate the appropriate
parameters going forward to encourage increasing liquidity providing
activity in RPI Orders on the Exchange.
---------------------------------------------------------------------------

    \5\ The proposed $0.0020 per share executed fee will be
available through September 30, 2023 but would not be available
thereafter. For example, as of October 1, 2023, the Exchange would
no longer offer the incentive.

---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange believes that its proposal is consistent with section
6(b) of the Act,\6\ in general, and furthers the objectives of sections
6(b)(4) and 6(b)(5) of the Act,\7\ in particular, in that it provides
for the equitable allocation of reasonable dues, fees and other charges
among members and issuers and other persons using any facility, and is
not designed to permit unfair discrimination between customers,
issuers, brokers, or dealers.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78f(b).
    \7\ 15 U.S.C. 78f(b)(4) and (5).
---------------------------------------------------------------------------

    The Exchange's proposed changes to its schedule of credits are
reasonable in several respects. As a threshold matter, the Exchange is
subject to significant competitive forces in the market for equity
securities transaction services that constrain its pricing
determinations in that market. The fact that this market is competitive
has long been recognized by the courts. In NetCoalition v. Securities
and Exchange Commission, the D.C. Circuit stated as follows: ``[n]o one
disputes that competition for order flow is `fierce.' . . . As the SEC
explained, `[i]n the U.S. national market system, buyers and sellers of
securities, and the broker-dealers that act as their order-routing
agents, have a wide range of choices of where to route orders for
execution'; [and] `no exchange can afford to take its market share
percentages for granted' because `no exchange possesses a monopoly,
regulatory or otherwise, in the execution of order flow from broker
dealers'. . . .'' \8\
---------------------------------------------------------------------------

    \8\ NetCoalition v. SEC, 615 F.3d 525, 539 (D.C. Cir. 2010)
(quoting Securities Exchange Act Release No. 59039 (December 2,
2008), 73 FR 74770, 74782-83 (December 9, 2008) (SR-NYSEArca-2006-
21)).
---------------------------------------------------------------------------

    The Commission and the courts have repeatedly expressed their
preference for competition over regulatory intervention in determining
prices, products, and services in the securities markets. In Regulation
NMS, while adopting a series of steps to improve the current market
model, the Commission highlighted the importance of market forces in
determining prices and SRO revenues and, also, recognized that current
regulation of the market system ``has been remarkably successful in
promoting market competition in its broader forms that are most
important to investors and listed companies.'' \9\
---------------------------------------------------------------------------

    \9\ Securities Exchange Act Release No. 51808 (June 9, 2005), 70
FR 37496, 37499 (June 29, 2005) (``Regulation NMS Adopting
Release'').
---------------------------------------------------------------------------

    Numerous indicia demonstrate the competitive nature of this market.
For example, clear substitutes to the Exchange exist in the market for
equity security transaction services. The Exchange is only one of
several equity venues to which market participants may direct their
order flow. Competing equity exchanges offer similar tiered pricing
structures to that of the Exchange, including schedules of rebates and
fees that apply based upon members achieving certain volume thresholds.
    Within this environment, market participants can freely and often
do shift their order flow among the Exchange and competing venues in
response to changes in their respective pricing schedules. As such, the
proposal represents a reasonable attempt by the Exchange to increase
its liquidity and market share relative to its competitors.
    The Exchange believes it is reasonable and equitable to adopt a new
$0.0020 per share executed fee for RPI Orders entered by a member that
(i) quotes Retail Price Improvement Orders in at least 1,200 symbols on
average per day; (ii) provides liquidity through Retail Price
Improvement Orders equal to or exceeding an average daily volume of
1,000,000 shares; and (iii) increases its average daily volume of
liquidity provided in Retail Price Improvement Orders at least 10%
relative to the month of March 2023. As discussed above, the Exchange's
goal is to increase liquidity adding activity in RPI Orders on its
platform, particularly relative to March 2023. It is reasonable and
equitable to address this need by providing a lower fee to members that
meet the proposed thresholds as an incentive for them to increase their
liquidity activity in RPI Orders on the Exchange relative to March
2023. If the proposal is effective in achieving this purpose, then the
quality of the Exchange's market will improve, particularly with
respect to RPI and Retail Orders to the benefit of all participants,
especially those who submit RPI and Retail Orders. The Exchange's
proposal to sunset the $0.0020 fee is also reasonable because the
Exchange believes that despite only offering this fee for four months,
the incentive may continue to encourage members to earn lower fees by
increasing liquidity providing activity in RPI Orders on the Exchange.
    The Exchange believes that the proposal is not unfairly
discriminatory. The Exchange intends for its proposal to improve market
quality for all members that submit RPI and Retail Orders on the
Exchange and by extension attract more liquidity to the market,
improving market wide quality and price discovery. Although net adders
of liquidity for RPI Orders will benefit most from the proposal, this
result is fair insofar as increased liquidity adding activity in RPI
Orders will help to improve market quality and the attractiveness of
the Nasdaq BX market to all existing and prospective retail
participants. The Exchange's proposal to sunset the incentive is
equitable and not unfairly discriminatory because the fee will be
available to all members during the four months it is offered.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition not necessary or appropriate in
furtherance of the purposes of the Act.
Intramarket Competition
    The Exchange does not believe that its proposal will place any
category of Exchange participant at a competitive disadvantage.
    As noted above, all members of the Exchange will benefit from any
increase in market activity that the proposal effectuates. Members may
modify their businesses so that they can meet the required thresholds
and pay lower charges. The Exchange's proposal to sunset the fee does
not impose an undue burden on competition because any member can
qualify for the fee during the four months it is offered. The Exchange
notes that its members are free to trade on other venues to the extent
they believe that the proposal is not attractive. As one can observe by
looking at any market share chart, price competition between exchanges
is fierce, with liquidity and market share moving freely between
exchanges in reaction to fee and credit changes.
Intermarket Competition
    In terms of inter-market competition, the Exchange notes that it
operates in a highly competitive market in which market participants
can readily favor competing venues if they deem fee levels at a
particular venue to be excessive, or rebate opportunities available at
other venues to be more favorable. In such an environment, the Exchange
must continually adjust its credits and fees to remain competitive with
other exchanges and with alternative trading systems that have been
exempted from compliance with the statutory standards applicable to
exchanges. Because competitors are free to modify their own credits and
fees in response, and because market participants may readily adjust
their order routing practices, the Exchange believes that the degree to
which credit or fee changes in this market may impose any burden on
competition is

extremely limited. The proposal is reflective of this competition.
    Even as one of the largest U.S. equities exchanges by volume, the
Exchange has less than 20% market share, which in most markets could
hardly be categorized as having enough market power to burden
competition. Moreover, as noted above, price competition between
exchanges is fierce, with liquidity and market share moving freely
between exchanges in reaction to fee and credit changes. This is in
addition to free flow of order flow to and among off-exchange venues,
which comprises upwards of 50% of industry volume.
    In sum, the Exchange intends for the proposed change to its fees
for RPI Orders, in the aggregate, to increase member incentives to
engage in the addition of liquidity on the Exchange. If the change
proposed herein is unattractive to market participants, it is likely
that the Exchange will lose market share as a result. Accordingly, the
Exchange does not believe that the proposed change will impair the
ability of members or competing order execution venues to maintain
their competitive standing in the financial markets.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were either solicited or received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change has become effective pursuant to section
19(b)(3)(A)(ii) of the Act.\10\
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78s(b)(3)(A)(ii).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is: (i)
necessary or appropriate in the public interest; (ii) for the
protection of investors; or (iii) otherwise in furtherance of the
purposes of the Act. If the Commission takes such action, the
Commission shall institute proceedings to determine whether the
proposed rule should be approved or disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's internet comment form (https://www.sec.gov/rules/sro.shtml); or
     Send an email to [email protected]. Please include
file number SR-BX-2023-15 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.
    All submissions should refer to file number SR-BX-2023-015. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's internet website (https://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for website viewing and
printing in the Commission's Public Reference Room, 100 F Street NE,
Washington, DC 20549, on official business days between the hours of 10
a.m. and 3 p.m. Copies of the filing also will be available for
inspection and copying at the principal office of the Exchange. Do not
include personal identifiable information in submissions; you should
submit only information that you wish to make available publicly. We
may redact in part or withhold entirely from publication submitted
material that is obscene or subject to copyright protection. All
submissions should refer to file number SR-BX-2023-15 and should be
submitted on or before July 5, 2023.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\11\
---------------------------------------------------------------------------

    \11\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Sherry R. Haywood,
Assistant Secretary.
[FR Doc. 2023-12660 Filed 6-13-23; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 79, Number 131 (Wednesday, July 9, 2014)]
[Notices]
[Page 39015]
[FR Doc No: 2014-16107]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meetings

    Notice is hereby given, pursuant to the provisions of the
Government in the Sunshine Act, Public Law 94-409, that the Securities
and Exchange Commission will hold a Closed Meeting on Thursday, July
10, 2014 at 2 p.m.
    Commissioners, Counsel to the Commissioners, the Secretary to the
Commission, and recording secretaries will attend the Closed Meeting.
Certain staff members who have an interest in the matters also may be
present.
    The General Counsel of the Commission, or her designee, has
certified that, in her opinion, one or more of the exemptions set forth
in 5 U.S.C. 552b(c)(3), (5), (7), 9(B) and (10) and 17 CFR
200.402(a)(3), (5), (7), 9(ii) and (10), permit consideration of the
scheduled matter at the Closed Meeting.
    Commissioner Stein, as duty officer, voted to consider the items
listed for the Closed Meeting in closed session.
    The subject matter of the Closed Meeting will be:

Institution and settlement of injunctive actions;
Institution and settlement of administrative proceedings; and
Other matters relating to enforcement proceedings.

    At times, changes in Commission priorities require alterations in
the scheduling of meeting items.
    For further information and to ascertain what, if any, matters have
been added, deleted or postponed, please contact the Office of the
Secretary at<PHONE_NUMBER>.

    Dated: July 3, 2014.
Lynn M. Powalski,
Deputy Secretary.
 [FR Doc. 2014-16107 Filed 7-7-14; 11:15 am]
BILLING CODE 8011-01-P


[Federal Register Volume 82, Number 127 (Wednesday, July 5, 2017)]
[Notices]
[Pages 31058-31060]
[FR Doc No: 2017-14088]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2010-0014; FRL-9962-88]

Product Cancellation Order for Certain Pesticide Registrations

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's order for the cancellations,
voluntarily requested by the registrants and accepted by the Agency, of
the products listed in Table 1 of Unit II., pursuant to the Federal
Insecticide, Fungicide, and Rodenticide Act (FIFRA). This cancellation
order follows a June 8, 2016 Federal Register Notice of Receipt of
Requests from the registrants listed in Table 2 of Unit II. to
voluntarily cancel these product registrations. In the June 8, 2016
notice, EPA indicated that it would issue an order implementing the
cancellations, unless the Agency received substantive comments within
the 180-day comment period that would merit its further review of these
requests, or unless the registrants withdrew their requests. The Agency
did not receive any comments on the notice. Further, the registrants
did not withdraw their requests. Accordingly, EPA hereby issues in this
notice a cancellation order granting the requested cancellations. Any
distribution, sale, or use of the products subject to this cancellation
order is permitted only in accordance with the terms of this order,
including any existing stocks provisions.

DATES: The cancellations are effective July 5, 2017.

FOR FURTHER INFORMATION CONTACT: Michael Yanchulis, Information
Technology and Resources Management Division (7502P), Office of
Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001; telephone number:<PHONE_NUMBER>;
email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general, and may be of
interest to a wide range of stakeholders including environmental, human
health, and agricultural advocates; the chemical industry; pesticide
users; and members of the public interested in the sale, distribution,
or use of pesticides. Since others also may be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action.

B. How can I get copies of this document and other related information?

    The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPP-2010-1014, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW., Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is<PHONE_NUMBER>, and the telephone number for the OPP
Docket is<PHONE_NUMBER>. Please review the visitor instructions and
additional information about the docket available at http://www.epa.gov/dockets.

II. What action is the agency taking?

    This notice announces the cancellations and/or amendment to
terminate uses, as requested by registrants, of products registered
under FIFRA section 3 (7 U.S.C. 136a). These registrations are listed
in sequence by registration number in Table 1 and Table 2 of this unit.
The following registration numbers that were listed in the Federal
Register of June 8, 2016 (81 FR 36913) (FRL-9943-68) have already been
cancelled in previous Federal Register notices: 81002-1 on September
18, 2015 (80 FR 56457); 9198-205 on October 3, 2016 (81 FR 68013); and
3525-71, 3525-91, 3525-96, 3525-109, CA-030012, MA-080001, OR-080035,
OR-100010 and TX-100019 on March 22, 2017 (82 FR 14717).

                     Table 1--Product Cancellations
------------------------------------------------------------------------
      Registration No.            Product name          Chemical name
------------------------------------------------------------------------
100-1244....................  Banner Dry Maxx.....  Propiconazole.
10324-56....................  Maquat 256..........  Alkyl* dimethyl
                                                     benzyl ammonium
                                                     chloride *(60%C14,
                                                     30%C16, 5%C18,
                                                     5%C12) and Alkyl*
                                                     dimethyl
                                                     ethylbenzyl
                                                     ammonium chloride
                                                     *(68%C12, 32%C14).
35935-41....................  Dithiopyr Technical.  Dithiopyr.
35935-49....................  Dynamo Dithiopyr      Dithiopyr.
                               Technical.
35935-75....................  Dithiopyr Technical.  Dithiopyr.
53883-207...................  Dithiopyr 0.13% Plus  Dithiopyr.
                               Fertilizer.
53883-208...................  Dithiopyr 0.25% Plus  Dithiopyr.
                               Fertilizer.
53883-209...................  Dithiopyr 0.172%      Dithiopyr.
                               Plus Fertilizer.
53883-210...................  Dithiopyr 0.107%      Dithiopyr.
                               Plus Fertilizer.
53883-211...................  Dithiopyr 0.06% Plus  Dithiopyr.
                               Fertilizer.
53883-212...................  Dithiopyr 0.086%      Dithiopyr.
                               Plus Fertilizer.
53883-213...................  Dithiopyr 0.1% Plus   Dithiopyr.
                               Fertilizer.
53883-268...................  Dithiopyr             Dithiopyr.
                               Concentrate for
                               Fertilizer.
53883-311...................  Dithiopyr 0.13% Plus  Dithiopyr.
                               Fertilizer.
66222-143...................  Alias 4F Flowable     Imidacloprid.
                               Insecticide.
AZ-080006...................  Brigade 2EC           Bifenthrin.
                               Insecticide/
                               Miticide.
ND-110002...................  Moncut 70-DF........  Flutolanil.
ND-130003...................  F7583-3 Herbicide...  S-Metolachlor and
                                                     Sulfentrazone.
OR-100003...................  TOPSIN M WSB........  Thiophanate-methyl.
SD-130008...................  SC 547 Herbicide....  Tembotrione and
                                                     Thiencarbazone-
                                                     methyl.
WA-090003...................  Topsin M 70WP.......  Thiophanate-methyl.
WA-930026...................  Rovral 4 Flowable     Iprodione.
                               Fungicide.
WA-940006...................  Rovral 4 Flowable     Iprodione.
                               Fungicide.
WA-960027...................  Rovral 4 Flowable     Iprodione.
                               Fungicide.
------------------------------------------------------------------------

                     Table 2--Product Registration Amendments To Terminate One or More Uses
----------------------------------------------------------------------------------------------------------------
         Registration No.                Product name             Chemical name            Uses to be deleted
----------------------------------------------------------------------------------------------------------------
524-475...........................  Roundup Ultra          Glyphosate-                 Seed production of
                                     Herbicide.             isopropylammonium.          creeping bentgrass with
                                                                                a Roundup Ready Gene.
----------------------------------------------------------------------------------------------------------------

    Table 3 of this unit includes the names and addresses of record for
all registrants of the products in Table 1 of this unit, in sequence by
EPA company number. This number corresponds to the first part of the
EPA registration numbers of the products listed in Table 1 of this
unit.

               Table 3--Registrants of Cancelled Products
------------------------------------------------------------------------
          EPA Company No.                 Company name and address
------------------------------------------------------------------------
100...............................  Syngenta Crop Protection, LLC, PO
                                     Box 18300, Greensboro, NC 27419.
524...............................  Monsanto Company, 1300 I Street,
                                     NW., Suite 450 East, Washington, DC
                                     20005-7211.
10324.............................  Mason Chemical Company, 723 W.
                                     Algonquin Road, Suite B, Arlington
                                     Heights, IL 60005.
35935.............................  Nufarm Limited (Agent to Nufarm
                                     Americas, Inc.), 4020 Aerial Center
                                     Parkway, Suite 101, Morrisville, NC
                                     27560.
53883.............................  Control Solutions, Inc., 5903 Genoa-
                                     Red Bluff Road, Pasadena, TX 77507-
                                     1041.
66222.............................  Makhteshim Agan of North America,
                                     Inc., 3120 Highwoods Blvd., Suite
                                     100, Raleigh, NC 27604.
AZ-080006, ND-130003..............  FMC Corp., 1735 Market Street, Room
                                     1971, Philadelphia, PA 19103.
ND-110002.........................  Gowan Company, P.O. Box 5569, Yuma,
                                     AZ 85366.
OR-100003, WA-090003..............  Nippon Soda Co., Ltd., 88 Pine
                                     Street, 14th Floor, New York, NY
                                     10005.
SD-130008, WA-930026, WA-940006,    Baryer Cropscience, LP, 2 T.W.
 WA-960027.                          Alexander Drive, P.O. Box 12014,
                                     Research Triangle Park, NC 27709.
------------------------------------------------------------------------

III. Summary of Public Comments Received and Agency Response to
Comments

    During the public comment period provided, EPA received two general
comments concerning the chemical, glyphosate. The Agency does not
believe that the comments submitted during the comment periods merits
further review or the denial of the requests for the voluntary
cancellations of products listed in Table 1 of Unit II or the request
for the amendment to terminate uses in Table 2 or Unit II.

IV. Cancellation Order

    Pursuant to FIFRA section 6(f) (7 U.S.C. 136d(f)), EPA hereby
approves the requested cancellations and/or amendment to terminate uses
of the registrations identified in Table 1 and Table 2 of Unit II.
Accordingly, the Agency hereby orders that the product registrations
identified in Table 1 of Unit II. are canceled and/or amended to
terminate the effective uses. The effective date of the cancellations
that are the subject of this notice is July 5, 2017. Any distribution,
sale, or use of existing stocks of the products identified in Table 1
of Unit II. in a manner inconsistent with any of the

provisions for disposition of existing stocks set forth in Unit VI.
will be a violation of FIFRA.

V. What is the agency's authority for taking this action?

    Section 6(f)(1) of FIFRA (7 U.S.C. 136d(f)(1)) provides that a
registrant of a pesticide product may at any time request that any of
its pesticide registrations be canceled or amended to terminate one or
more uses. FIFRA further provides that, before acting on the request,
EPA must publish a notice of receipt of any such request in the Federal
Register. Thereafter, following the public comment period, the EPA
Administrator may approve such a request. The notice of receipt for
this action was published for comment in the Federal Register of June
8, 2016 (81 FR 36913) (FRL-9943-68). The comment period closed on
December 5, 2016.

VI. Provisions for Disposition of Existing Stocks

    Existing stocks are those stocks of registered pesticide products
which are currently in the United States and which were packaged,
labeled, and released for shipment prior to the effective date of the
cancellation action. The existing stocks provisions for the products
subject to this order are as follows.
    The registrant(s) may continue to sell and distribute existing
stocks of product(s) listed in Table 1 of Unit II. until July 5, 2018,
which is 1 year after the publication of the Cancellation Order in the
Federal Register. Thereafter, the registrants are prohibited from
selling or distributing products listed in Table 1, except for export
in accordance with FIFRA section 17 (7 U.S.C. 136o), or proper
disposal. Persons other than the registrants may sell, distribute, or
use existing stocks of products listed in Table 1 of Unit II. until
existing stocks are exhausted, provided that such sale, distribution,
or use is consistent with the terms of the previously approved labeling
on, or that accompanied, the canceled products.

    Authority: 7 U.S.C. 136 et seq.

    Dated: May 25, 2017.
Delores Barber,
Director, Information Technology and Resources Management Division,
Office of Pesticide Programs.
[FR Doc. 2017-14088 Filed 7-3-17; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 87, Number 166 (Monday, August 29, 2022)]
[Rules and Regulations]
[Pages 52663-52665]
[FR Doc No: 2022-18538]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2021-0958; Project Identifier 2019-CE-010-AD; Amendment
39-22133; AD 2022-16-04]
RIN 2120-AA64

Airworthiness Directives; Gulfstream Aerospace Corporation
Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The FAA is correcting an airworthiness directive (AD) that
published in the Federal Register. That AD applies to all Gulfstream
Aerospace Corporation (Gulfstream) Model GV and GV-SP airplanes. As
published, a revision level and a table number in certain document
citations in the Credit for Previous Actions section of the regulatory
text are incorrect. This document corrects those errors. In all other
respects, the original document remains the same.

DATES: This correction is effective September 7, 2022. The effective
date of AD 2022-16-04 remains September 7, 2022.
    The Director of the Federal Register approved the incorporation by
reference of certain publications listed in this AD as of September 7,
2022 (87 FR 47337, August 3, 2022).

ADDRESSES:
    AD Docket: You may examine the AD docket at regulations.gov by
searching for and locating Docket No. FAA-2021-0958; or in person at
Docket Operations between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The AD docket contains this final rule, any
comments received, and other information. The address for Docket
Operations is U.S. Department of Transportation, Docket Operations, M-
30, West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue
SE, Washington, DC 20590.
    Material Incorporated by Reference:
     For service information identified in this final rule,
contact Gulfstream Aerospace Corporation, Technical Publications Dept.,
P.O. Box 2206, Savannah, GA 31402; phone:<PHONE_NUMBER>; fax: (912)
965-3520; email: [email protected]; website: gulfstream.com/en/customer-support/.
     You may view this referenced service information at the
FAA, Airworthiness Products Section, Operational Safety Branch, 901
Locust, Kansas City, MO 64106. For information on the availability of
this material at the FAA, call<PHONE_NUMBER>. It is also available at
regulations.gov by searching for and locating Docket No. FAA-2021-0958.

FOR FURTHER INFORMATION CONTACT: Ronald Wissing, Aviation Safety
Engineer, Atlanta ACO Branch, FAA, 1701 Columbia Avenue, College Park,
GA 30337; phone:<PHONE_NUMBER>; email: [email protected].

SUPPLEMENTARY INFORMATION: AD 2022-16-04, Amendment 39-22133 (87 FR
47337, August 3, 2022) (AD 2022-16-04), requires inspecting the
horizontal stabilizer lower skin and associated bonded doublers and
bonded stringers, repairing any area with corrosion beyond allowable
damage limits, and incorporating revisions to the airworthiness
limitations section (ALS) in the existing aircraft maintenance manual
(AMM) or progressive maintenance program for all Gulfstream Model GV
and GV-SP airplanes.

Need for the Correction

    As published, the regulatory text of AD 2022-16-04 includes the
following errors:
     The revision level of the Gulfstream V Aircraft
Maintenance Manual specified in paragraph (j)(1) of the regulatory text
is incorrectly identified as ``Revision 53.'' The correct revision for
February 28, 2020, is ``Revision 51''; and
     The number specified for the Horizontal Stabilizer
Inspection Table in the document citation in paragraph (j)(2) of the
regulatory text is incorrectly referenced as ``Table 11.'' The correct
reference is ``Table 12.''

Related Service Information Under 1 CFR Part 51

    The FAA reviewed Gulfstream G500-5000 Customer Bulletin No. 190,
Revision B; Gulfstream G550 Customer Bulletin No. 190, Revision B; and
Gulfstream GV Customer Bulletin No. 228, Revision B; all dated October
31, 2019. For the applicable marketing designation specified on each
document, the customer bulletins specify procedures for inspecting the
horizontal stabilizer lower bonded skin.
    The FAA also reviewed Section F and Table 12: Horizontal Stabilizer
Inspection Table in Section 05-10-10, Airworthiness Limitations, of
Chapter 05, Time Limits/Maintenance Checks, of the Gulfstream V
Aircraft Maintenance Manual, Revision 55, dated March 15, 2022; Section
F and Table 11: Horizontal Stabilizer Inspection Table in Section 05-
10-10, Airworthiness Limitations, of Chapter 05, Time Limits/

Maintenance Checks, of the Gulfstream G500-5000 Aircraft Maintenance
Manual, Revision 36, dated March 15, 2022; and Section F and Table 11:
Horizontal Stabilizer Inspection Table in Section 05-10-10,
Airworthiness Limitations, of Chapter 05, Time Limits/Maintenance
Checks, of the Gulfstream G550 Aircraft Maintenance Manual, Revision
36, dated March 15, 2022. For the applicable marketing designation
specified on each document, the service information contains inspection
intervals for nondestructive testing of the lower horizontal stabilizer
skins and provides the specific reference for the inspection
procedures.
    This service information is reasonably available because the
interested parties have access to it through their normal course of
business or by the means identified in the ADDRESSES section.

Correction of Publication

    This document corrects two typographical errors and correctly adds
the AD as an amendment to 14 CFR 39.13. Although no other part of the
preamble or regulatory information has been corrected, the FAA is
republishing the entire rule in the Federal Register.
    The effective date of this AD remains September 7, 2022.
    Since this action only corrects a revision level and table number
in document citations in the regulatory text, it has no adverse
economic impact and imposes no additional burden on any person.
Therefore, the FAA has determined that notice and public procedures are
unnecessary.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

Adoption of the Correction

    Accordingly, under the authority delegated to me by the
Administrator, the FAA corrects 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Corrected]

0
2. The FAA corrects Sec.  39.13 by correcting the airworthiness
directive published at 87 FR 47337 (August 3, 2022) to read:

2022-16-04 Gulfstream Aerospace Corporation: Amendment 39-22133;
Docket No. FAA-2021-0958; Project Identifier 2019-CE-010-AD.

(a) Effective Date

    This airworthiness directive (AD) is effective September 7,
2022.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to Gulfstream Aerospace Corporation Model GV and
GV-SP airplanes, all serial numbers, certificated in any category.
    Note 1 to paragraph (c): Model GV-SP airplanes are also referred
to by the marketing designations G500, G550, and G500-5000.

(d) Subject

    Joint Aircraft System Component (JASC) Code 5510, Horizontal
Stabilizer Structure.

(e) Unsafe Condition

    This AD results from corrosion of the horizontal stabilizer
lower bonded skin assemblies. The FAA is issuing this AD to detect
and correct bond line corrosion, which if not addressed, could
result in compromise of the structural integrity of the horizontal
stabilizer and lead to loss of control of the airplane.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Incorporation of Airworthiness Limitations (ALS) Revisions

    Within 30 days after the effective date of this AD, incorporate
into your existing maintenance or inspection program the ALS
revision specified in paragraph (g)(1), (2), or (3) of this AD for
your applicable airplane designation.
    (1) For Model GV airplanes: Section F and Table 12: Horizontal
Stabilizer Inspection Table in Section 05-10-10, Airworthiness
Limitations, of Chapter 05, Time Limits/Maintenance Checks, of the
Gulfstream V Aircraft Maintenance Manual, Revision 55, dated March
15, 2022.
    (2) For Model GV-SP (G500 and G500-5000) airplanes: Section F
and Table 11: Horizontal Stabilizer Inspection Table in Section 05-
10-10, Airworthiness Limitations, of Chapter 05, Time Limits/
Maintenance Checks, of the Gulfstream G500-5000 Aircraft Maintenance
Manual, Revision 36, dated March 15, 2022.
    (3) For Model GV-SP (G550) airplanes: Section F and Table 11:
Horizontal Stabilizer Inspection Table in Section 05-10-10,
Airworthiness Limitations, of Chapter 05, Time Limits/Maintenance
Checks, of the Gulfstream G550 Aircraft Maintenance Manual, Revision
36, dated March 15, 2022.

(h) Applicable Customer Bulletins

    The customer bulletins specified in paragraphs (h)(1) through
(3) of this AD contain procedures for compliance with the actions
required by paragraph (i) of this AD for your applicable airplane
designation:
    (1) Gulfstream GV Customer Bulletin No. 228, Revision B, dated
October 31, 2019;
    (2) Gulfstream G500-5000 Customer Bulletin No. 190, Revision B,
dated October 31, 2019; or
    (3) Gulfstream G550 Customer Bulletin No. 190, Revision B, dated
October 31, 2019.

(i) Inspection

    For Model GV airplanes, all serial numbers, and Model GV-SP
airplanes, serial numbers 5001 through 5158: Within 12 months after
the effective date of this AD, perform the horizontal stabilizer
lower skin resonance C-Scan inspection (Part II inspection) for bond
line corrosion and apply corrosion inhibiting compound (CIC) by
following steps 6.2.a. through 6.2.e. and 6.3.a. of appendix A of
the applicable customer bulletin listed in paragraph (h) of this AD.
    Note 2 to the introductory text of paragraph (i): Operators may
align the inspections listed in the applicable ALS revision in
paragraph (g) of this AD with the Part II inspection.
    (1) Within 48 months after applying CIC, repair all bond line
corrosion.
    (2) If there is bond line corrosion that exceeds the allowable
damage limits in Table 2 of appendix A of the applicable customer
bulletin listed in paragraph (h) of this AD, or other allowable
damage limits established by an appropriately authorized Gulfstream
Organization Designation Authorization (ODA) unit member, repair all
bond line corrosion before further flight using a repair approved by
the FAA or an appropriately authorized Gulfstream ODA unit member.
    (i) For a repair method to be approved by the FAA, the FAA's
approval of the repair must specifically refer to this AD.
    (ii) For a repair method to be approved by a Gulfstream ODA unit
member, the unit member must be authorized in writing by the Manager
of the Atlanta ACO Branch to approve repairs for this AD, and the
unit member's approval of the repair must specifically refer to this
AD.

(j) Credit for Previous Actions

    You may take credit for the ALS revision required by paragraph
(g) of this AD if you revised the ALS before the effective date of
this AD using the service information specified in paragraph (j)(1),
(2), or (3) of this AD, as applicable to your airplane designation.
    (1) For Model GV airplanes: Section F and Table 12: Horizontal
Stabilizer Inspection Table in Section 05-10-10, Airworthiness
Limitations, of Chapter 05, Time Limits/Maintenance Checks, of the
Gulfstream V Aircraft Maintenance Manual, Revision 51, dated
February 28, 2020.
    (2) For Model GV-SP (G500 and G500-5000) airplanes: Section F
and Table 12: Horizontal Stabilizer Inspection Table in Section 05-
10-10, Airworthiness Limitations, of Chapter 05, Time Limits/
Maintenance Checks, of the Gulfstream G500-5000 Aircraft Maintenance
Manual, Revision 34, dated March 15, 2021.
    (3) For Model GV-SP (G550) airplanes: Section F and Table 12:
Horizontal Stabilizer Inspection Table in Section 05-10-10,
Airworthiness Limitations, of Chapter 05, Time Limits/Maintenance
Checks, of the Gulfstream G550 Aircraft Maintenance Manual, Revision
34, dated March 15, 2021.

(k) Alternative Methods of Compliance (AMOCs)

    (1) The Manager, Atlanta ACO Branch, FAA, has the authority to
approve AMOCs for this AD, if requested using the procedures found
in 14 CFR 39.19. In accordance with 14 CFR 39.19, send your request
to your principal inspector or local Flight Standards District
Office, as appropriate. If sending information directly to the
manager of the certification office, send it to the attention of the
person identified in paragraph (l)(1) of this AD.
    (2) Before using any approved AMOC, notify your appropriate
principal inspector, or lacking a principal inspector, the manager
of the local flight standards district office/certificate holding
district office.
    (3) An AMOC that provides an acceptable level of safety may be
used for any repair, modification, or alteration required by this AD
if it is approved by a Gulfstream Engineering Authorized
Representative (EAR) of the Gulfstream ODA that has been authorized
by the Manager, Atlanta ACO Branch, to make those findings. To be
approved, the repair, modification deviation, or alteration
deviation must meet the certification basis of the airplane, and the
approval must specifically refer to this AD.
    (4) For service information that contains steps that are labeled
as Required for Compliance (RC), the following provisions apply.
    (i) The steps labeled as RC, including substeps under an RC step
and any figures identified in an RC step, that are required by
paragraph (i) of this AD must be done to comply with this AD. An
AMOC is required for any deviations to RC steps required by
paragraph (i) of this AD, including substeps and identified figures.
    (ii) Steps not labeled as RC may be deviated from using accepted
methods in accordance with the operator's maintenance or inspection
program without obtaining approval of an AMOC, provided the RC
steps, including substeps and identified figures, can still be done
as specified, and the airplane can be put back in an airworthy
condition.

(l) Related Information

    (1) For more information about this AD, contact Ronald Wissing,
Aviation Safety Engineer, Atlanta ACO Branch, FAA, 1701 Columbia
Avenue, College Park, GA 30337; phone:<PHONE_NUMBER>; email: [email protected].
    (2) Service information identified in this AD that is not
incorporated by reference is available at the addresses specified in
paragraphs (m)(4) and (5) of this AD.

(m) Material Incorporated by Reference

    (1) The Director of the Federal Register approved the
incorporation by reference (IBR) of the service information listed
in this paragraph under 5 U.S.C. 552(a) and 1 CFR part 51.
    (2) You must use this service information as applicable to do
the actions required by this AD, unless the AD specifies otherwise.
    (3) The following service information was approved for IBR on
September 7, 2022 (87 FR 47337, August 3, 2022).
    (i) Gulfstream G500-5000 Customer Bulletin No. 190, Revision B,
dated October 31, 2019.
    (ii) Gulfstream G550 Customer Bulletin No. 190, Revision B,
dated October 31, 2019.
    (iii) Gulfstream GV Customer Bulletin No. 228, Revision B, dated
October 31, 2019.
    (iv) Section F and Table 11: Horizontal Stabilizer Inspection
Table in Section 05-10-10, Airworthiness Limitations, of Chapter 05,
Time Limits/Maintenance Checks, of the Gulfstream G500-5000 Aircraft
Maintenance Manual, Revision 36, dated March 15, 2022.
    (v) Section F and Table 11: Horizontal Stabilizer Inspection
Table in Section 05-10-10, Airworthiness Limitations, of Chapter 05,
Time Limits/Maintenance Checks, of the Gulfstream G550 Aircraft
Maintenance Manual, Revision 36, dated March 15, 2022.
    (vi) Section F and Table 12: Horizontal Stabilizer Inspection
Table in Section 05-10-10, Airworthiness Limitations, of Chapter 05,
Time Limits/Maintenance Checks, of the Gulfstream V Aircraft
Maintenance Manual, Revision 55, dated March 15, 2022.
    (4) For service information identified in this AD, contact
Gulfstream Aerospace Corporation, Technical Publications Dept., P.O.
Box 2206, Savannah, GA 31402; phone:<PHONE_NUMBER>; fax: (912) 965-
3520; email: [email protected]; website: gulfstream.com/en/customer-support/.
    (5) You may view this service information at FAA, Airworthiness
Products Section, Operational Safety Branch, 901 Locust, Kansas
City, MO 64106. For information on the availability of this material
at the FAA, call<PHONE_NUMBER>.
    (6) You may view this service information that is incorporated
by reference at the National Archives and Records Administration
(NARA). For information on the availability of this material at
NARA, email: [email protected], or go to: archives.gov/federal-register/cfr/ibr-locations.html.

    Issued on August 24, 2022.
Gaetano A. Sciortino,
Deputy Director for Strategic Initiatives, Compliance & Airworthiness
Division, Aircraft Certification Service.
[FR Doc. 2022-18538 Filed 8-26-22; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 81, Number 245 (Wednesday, December 21, 2016)]
[Notices]
[Pages 93681-93682]
[FR Doc No: 2016-30760]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OW-2015-0335; FRL-9956-93-OW]

Final EPA-USGS Technical Report: Protecting Aquatic Life from
Effects of Hydrologic Alteration

AGENCY: Environmental Protection Agency (EPA) and United States
Geological Survey (USGS).

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) and the United
States Geological Survey are releasing a technical report: Final EPA-
USGS Technical Report: Protecting Aquatic Life from Effects of
Hydrologic Alteration. Healthy aquatic ecosystems provide an array of
services to individuals and society, including clean drinking water,
irrigation supplies, and recreational opportunities. Sound and
sustainable management of aquatic ecosystems is an integral part of
managing water resources to meet the needs of society. Hydrologic
alteration can be a contributor to the impairment of water bodies that
are designated to support aquatic life. Stresses on aquatic life
associated with hydrologic alteration may be further exacerbated by
climate change.
    This report provides States, Tribes and territories with scientific
and technical information on the natural flow regime and potential
effects of flow alteration on aquatic life, and a flexible,
nonprescriptive framework that state water managers might consider if
they are interested in developing narrative or numeric targets for flow
regime components that are protective of aquatic life. The report also
provides information about States and Tribes that have adopted
narrative water quality standards to protect their waterbodies' flow
regimes and on the potential impact of climate change on flow regimes.

FOR FURTHER INFORMATION CONTACT: Diana Eignor, Health and Ecological
Criteria Division, Office of Water (Mail Code 4304T), Environmental
Protection Agency, 1200 Pennsylvania Avenue NW., Washington, DC 20460;
telephone number:<PHONE_NUMBER>; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. How can I get copies of this document and other related information?

    1. Docket: All documents in the docket are listed in the
www.regulations.gov index. Although listed in the index, some
information is not publicly available, e.g., CBI or other information
whose disclosure is restricted by statute. Certain other material, such
as copyrighted material, will be publicly available only in hard copy.
Publicly available docket materials are available either electronically
in www.regulations.gov or in hard copy at the Water Docket, EPA/DC, EPA
West, Room 3334, 1301 Constitution Ave. NW., Washington, DC. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is<PHONE_NUMBER>, and the telephone number for the Water
Docket is<PHONE_NUMBER>. For additional

information about EPA's public docket, visit EPA Docket Center homepage
at http://www.epa.gov/epahome/dockets.htm.

II. What is this document?

    This document serves as a technical and informational resource for
States, Tribes, territories, and other stakeholders that want to
protect aquatic life from the adverse effects of flow alteration. To
that end, this report provides technical information about the effect
of altered flow regimes on aquatic life and a nonprescriptive framework
that may be used to help quantify targets for flow regime components
that are protective of aquatic life and their habitats. The report also
provides examples of state and tribal water quality standards designed
to protect such flow regimes and discusses the potential impact of
climate change on flow regimes. This technical report is not a rule and
it, therefore, does not impose any mandatory requirements. State and
Tribal decision makers retain the discretion to adopt approaches or
information presented in this report on a case-by-case basis that
differ from the approaches described in this report.

III. Additional Information:

    EPA and USGS each conducted internal peer reviews of the report,
and EPA managed a contractor-led independent external peer review of
the Draft EPA-USGS Technical Report: Protecting Aquatic Life from
Effects of Hydrologic Alteration. EPA will make the external peer
review comments and Agency responses to these comments available in the
docket at http://www.regulations.gov.

    Dated: December 14, 2016.
Joel Beauvais,
Deputy Assistant Administrator, Office of Water.
[FR Doc. 2016-30760 Filed 12-20-16; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register: May 5, 2006 (Volume 71, Number 87)]
[Notices]
[Page 26493]
[DOCID:fr05my06-59]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 2232-485-NC]

Duke Power, a Division of Duke Energy Corporation; Notice of
Availability of Draft Environmental Assessment

April 28, 2006.
    In accordance with the National Environmental Policy Act of 1969
and the Federal Energy Regulatory Commission's (Commission)
regulations, 18 CFR part 380 (Order No. 486, 52 FR 47897), the Office
of Energy Projects has reviewed an application for non-project use of
project lands and waters at the Catawba-Wateree Project (FERC No.
2232), and has prepared a draft environmental assessment (DEA) for the
proposal. The proposed non-project use would be located on Lake James
in McDowell County, North Carolina.
    In the application, Duke Power (licensee) requests Commission
authorization to lease to Black Bear Development, Inc. 6.57 acres of
project land for a commercial/non-residential marina. The marina would
be located on Lake James at the Bear Cliff Community, a planned
lakefront development combining a private residential development and a
public day-use area. The DEA contains the Commission staff's analysis
of the probable environmental impacts of the proposed marina.
    The DEA is available for review and reproduction at the
Commission's Public Reference Room, located at 888 First Street, NE.,
Room 2A, Washington, DC 20426. The DEA may also be viewed on the
Commission's Web site at http://www.ferc.gov using the ``elibrary''

link. Enter the dock number (prefaced by P-) and excluding the last
three digits, in the docket number field to access the document. For
assistance, contact FERC Online Support at<EMAIL_ADDRESS>or toll-free at<PHONE_NUMBER>, or for TTY, contact<PHONE_NUMBER>.
    Comments on the DEA should be filed within 30 days of the date of
this notice and should be addressed to Magalie Roman Salas, Secretary,
Federal Energy Regulatory Commission, 888 First Street, NE.,
Washington, DC 20426. Please reference ``Catawba-Wateree Project, FERC
Project No. 2232-485'' on all comments. Comments may be filed
electronically via the Internet in lieu of paper. See, 18 CFR
385.2001(a)(1)(iii) and the instructions on the Commission's Web site
under the ``e-Filing'' link.

Magalie R. Salas,
Secretary.
[FR Doc. E6-6852 Filed 5-4-06; 8:45 am]

BILLING CODE 6717-01-P


 Forwarded by Vivian Prunier/ DC/ USEPA/ US on 08/ 07/ 2003 12: 19 PM

Margie Fehrenbach 06/ 25/ 2003 05: 08 PM To: cbaker@ gowanco. com, cwbrickey@ aol. com, pbright@ abcbirds. org, screscenzi@ steptoe. com, lelworth@ agcenter. org, ccqc1946@ pacbell. net, Ted. Head@ us. nufarm. com, Skellner@ cpsa. org, glibman@ att. net, lori@ yurok. com, therese. murtaugh@ usda. gov, perreault. peg@ epa. gov, pquinn@ theaccordgroup. com, rosenberg@ pestworld. org, rutzs@ doacs. state. fl julie. spagnoli. b@ bayer. com, nefcon@ aol. com, warren@ cpda. com, jvroom@ croplifeamerica. org, wichterman@ lcmcd. org, eolson@ nrdc. org, Britt@ cetos. org cc: Jim Jones/ DC/ USEPA/ US@ EPA, Anne Lindsay/ DC/ USEPA/ US@ EPA, Jay Ellenberger/ DC/ USEPA/ US@ EPA, Lin Moos/ DC/ USEPA/ US@ EPA, Betty Shackleford/ DC/ USEPA/ US@ EPA, Richard Keigwin/ DC/ USEPA/ US@ EPA, Viv Prunier/ DC/ USEPA/ US@ EPA, Bruce Sidwell/ DC/ USEPA/ US@ EPA, Luis Suguiyama/ DC/ USEPA/ US@ EPA, Joseph Bailey/ DC/ USEPA/ US@ EPA, Willia Jordan/ DC/ USEPA/ US@ EPA Subject: Establishment of PPDC Registratoin Review Work Group and July 2 Teleconference Call June 25, 2003 Dear PPDC Registration Review Workgroup Members:

Thank you for volunteering to serve on the PPDC Registration Review Workgroup. Betty Shackleford and I appreciate your commitment to public service through your participation on this workgroup. We look forward to your advice and recommendations for the PPDC so that the Agency can develop a registration review program that is efficient and fair to all stakeholders, focuses on risk reduction, and considers user needs for agricultural, non agricultural and public health pesticides. Under FIFRA section 3( g), EPA must publish procedures for reviewing pesticides every fifteen years. At the April PPDC meeting, EPA described a possible process for accomplishing registration review. A copy of this presentation is attached.

As you will recall from our May 30 e mail message and Mission Statement ( copy attached), the purpose of the PPDC Registration Review Workgroup is to receive stakeholder views and recommendations on the design of the registration review program. We expect the Workgroup to present its findings at the October 2003 meeting of the PPDC.

Twenty two people agreed to serve on this workgroup. In keeping with our goal to have a well balanced group, the members represent a broad spectrum of interests including representatives from industry, government, user organizations and public interest groups. A membership roster is attached.

A teleconference call to discuss ministerial details for this work group has been set for Wednesday, July 2, from 2: 00  4: 00 p. m. Eastern Daylight Time. To participate in the teleconference, please call 800 508 7731. Then, enter the meeting number, * 4639092*. Please remember to enter the asterisks (*) preceding and following the meeting number.

We apologize for the short notice and recognize that you may have commitments that preclude your participation in the July 2 teleconference. We will send minutes of the meeting and make every effort to bring you up to date regarding the July 2 discussion.

At this teleconference, we will discuss logistics for future meetings, review the topics that EPA is asking the workgroup to consider, and decide on the agenda for the next meeting. The agenda for the July 2 teleconference is appended below.

Please contact Vivian Prunier or Margie Fehrenbach if you need assistance or if you have any concerns. Vivian can be reached at 703 308 9341 or at Prunier. Vivian@ epa. gov. Margie can be reached at 703 308 4775 or at Fehrenbach. Margie@ epa. gov. We look forward to speaking with you during our teleconference next week.

Sincerely yours,

Jay Ellenberger and Betty Shackleford Co Chairs, PPDC Registration Review Workgroup Attachments:

ROSTER for the PPDC Registration Review Work Group


[Federal Register Volume 85, Number 133 (Friday, July 10, 2020)]
[Notices]
[Page 41581]
[FR Doc No: 2020-14908]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER20-2314-000]

RWE Renewables QSE, LLC; Supplemental Notice That Initial Market-
Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced proceeding of
RWE Renewables QSE, LLC's application for market-based rate authority,
with an accompanying rate tariff, noting that such application includes
a request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE, Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is July 27, 2020.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically may mail similar pleadings to
the Federal Energy Regulatory Commission, 888 First Street NE,
Washington, DC 20426. Hand delivered submissions in docketed
proceedings should be delivered to Health and Human Services, 12225
Wilkins Avenue, Rockville, Maryland 20852.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (http://ferc.gov) using the
``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. At this time,
the Commission has suspended access to the Commission's Public
Reference Room, due to the proclamation declaring a National Emergency
concerning the Novel Coronavirus Disease (COVID-19), issued by the
President on March 13, 2020. For assistance, contact the Federal Energy
Regulatory Commission at<EMAIL_ADDRESS>or call toll-free,
(886) 208-3676 or TYY,<PHONE_NUMBER>.

    Dated: July 6, 2020.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2020-14908 Filed 7-9-20; 8:45 am]
BILLING CODE 6717-01-P